Ignite Creation Date:
2024-05-05 @ 5:23 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00440167
Status:
UNKNOWN
Last Update Posted:
2012-07-09
First Post:
2007-02-22
Brief Title:
CapecitabineErlotinib Followed of Gemcitabine Versus GemcitabineErlotinib Followed of Capecitabine
Sponsor:
PD Dr med Volker Heinemann
Organization:
Ludwig-Maximilians - University of Munich
Organization Data
Organization:
Ludwig-Maximilians - University of Munich
Class:
OTHER
Study ID:
RC-57 crossover
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
PD Dr med Volker Heinemann
Lead Sponsor Class:
OTHER
Responsible Party:
PD Dr med Volker Heinemann
Responsible Party Title:
Sponsor Delegatated Person
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Ludwig-Maximilians - University of Munich
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Roche Pharma AG | INDUSTRY |